Very simply, we can say that the term cannabinoid generically refers to one of the substances found or extracted from […]
Cannabis Sativa is a plant with more than 500 chemical compounds, with more than 100 identified cannabinoids. Flavonoids, alkaloids, fatty acids and terpenes are in their formulation. The most studied phytocannabinoid compounds to date are cannabidiol, or CBD, and tetrahydrocannabinol, or THC.
Several researches today reveal the pharmacological properties of cannabis and prove its interaction with the endocannabinoid system, exposing its therapeutic potential for several diseases.
Cannabidiol is a phytocannabinoid without intoxicating properties. It has analgesic, anti-inflammatory, antioxidant, anxiolytic, antidepressant, anticonvulsant, bone stimulant, anti-nausea, neuroprotective capabilities and has an immunomodulatory effect. CBD also modulates the negative effects of THC, such as those related to unwanted psychoactive events, such as anxiety, depression or hallucinations.
THC, known as tetrahydrocannabinol – a phytocannabinoid with psychoactive properties, responsible for the sensations described as euphoria and loss of recent memory -, also has important medicinal properties. It is a potent stimulant of hunger, muscle relaxant, sedative, analgesic, anti-nausea and vomiting (mainly those induced by chemotherapy), anti-inflammatory and for some people it has a positive effect on mood.
However, it is not without side effects. They often prevent some patients from using it, due to effects such as anxiety, depression, momentary increase in heart rate and, as I said earlier, it can impair recent memory.
Current studies, in animal models and cell cultures, prove the antitumor properties of cannabinoids. Research carried out by a large pharmaceutical company in Great Britain, specializing in research with the Cannabis Sativa plant for medicinal use, concluded at the end of a study with neuro-oncological patients that cannabis had a positive effect on the survival of this population.